Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55gag

A Bojak, J Wild, H Wolf, R Wagner - Vaccine, 2002 - Elsevier
A Bojak, J Wild, H Wolf, R Wagner
Vaccine, 2002Elsevier
Most studies on DNA-based immunization have used viral promoters to drive antigen
expression. Recently, the use of tissue-specific DNA vaccines has been favored regarding
safety issues. In this study, we determined the impact of antigen localization and tissue-
specific expression on the induction of humoral as well as cellular immune responses in a
BALB/c mouse model. Thereby, we show that using the muscle-specific muscle creatine
kinase (MCK) promoter/enhancer the efficiency of immune stimulation is strictly dependent …
Most studies on DNA-based immunization have used viral promoters to drive antigen expression. Recently, the use of tissue-specific DNA vaccines has been favored regarding safety issues. In this study, we determined the impact of antigen localization and tissue-specific expression on the induction of humoral as well as cellular immune responses in a BALB/c mouse model. Thereby, we show that using the muscle-specific muscle creatine kinase (MCK) promoter/enhancer the efficiency of immune stimulation is strictly dependent on the ability of HIV-1 Pr55gag to be released from cells. By contrast, localization of Pr55gag and derivatives thereof plays only a minor role when antigen is constitutively expressed using the ubiquitous viral CMV promoter.
Elsevier